Literature DB >> 20586854

Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis.

Tomohisa Takagi1, Yuji Naito, Katsura Mizushima, Ikuhiro Hirata, Nobuaki Yagi, Naoya Tomatsuri, Takashi Ando, Yuichi Oyamada, Yutaka Isozaki, Hitoshi Hongo, Kazuhiko Uchiyama, Osamu Handa, Satoshi Kokura, Hiroshi Ichikawa, Toshikazu Yoshikawa.   

Abstract

BACKGROUND AND AIMS: MicroRNA (miRNA) are endogenous, approximately 22-nucleotide non-coding RNA that suppress gene expression at post-transcriptional levels by binding to the 3'-untranslated region of specific mRNA targets through base-pairing. It has been recently reported that miRNA have critical functions in key biological processes such as cell proliferation and cell death in various cancer cells. However, the relationship between intestinal inflammation and miRNA expression remains unclear. In the present study, we used microarray technology to identify miRNA induced in the colonic mucosa of patients with active ulcerative colitis (UC).
METHODS: Two colonic biopsy specimens from patients with active stage (>Matts grade 2) of UC under colonoscopy and two colonic biopsy specimens from healthy volunteers were obtained for gene expression profiles. Total RNA was extracted, and miRNA expression profiles were investigated using miRNA Microarray. Subsequently, to confirm the result of the Microarray investigation, we checked the expression of several selected miRNA using real-time polymerase chain reaction (PCR) in 12 colonic biopsy specimens from patients with active UC under colonoscopy and 12 specimens from the healthy volunteers.
RESULTS: In the microarray study, the expression of several miRNA was upregulated in the colonic mucosa of patients with active UC. Furthermore, two miRNA (miR-21, miR-155) were selected in the study using real-time PCR.
CONCLUSION: Upregulated miRNA may be responsible for the development of intestinal inflammation in UC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586854     DOI: 10.1111/j.1440-1746.2009.06216.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  88 in total

1.  Regulation of acute graft-versus-host disease by microRNA-155.

Authors:  Parvathi Ranganathan; Catherine E A Heaphy; Stefan Costinean; Nicole Stauffer; Caroline Na; Mehdi Hamadani; Ramasamy Santhanam; Charlene Mao; Patricia A Taylor; Sukhinder Sandhu; Gang He; Arwa Shana'ah; Gerard J Nuovo; Alessandro Lagana; Luciano Cascione; Susanna Obad; Oliver Broom; Sakari Kauppinen; John C Byrd; Michael Caligiuri; Danilo Perrotti; Gregg A Hadley; Guido Marcucci; Steven M Devine; Bruce R Blazar; Carlo M Croce; Ramiro Garzon
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

Review 2.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

3.  Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice.

Authors:  Dora Lippai; Shashi Bala; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2014-08       Impact factor: 3.455

Review 4.  MicroRNAs in inflammatory bowel disease.

Authors:  Joel R Pekow; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2011-03-18       Impact factor: 5.325

5.  Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40.

Authors:  Xiaochang Xue; Ting Feng; Suxia Yao; Kyle J Wolf; Chang-Gong Liu; Xiuping Liu; Charles O Elson; Yingzi Cong
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

6.  miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.

Authors:  Mehmet Coskun; Jacob Tveiten Bjerrum; Jakob Benedict Seidelin; Jesper Thorvald Troelsen; Jørgen Olsen; Ole Haagen Nielsen
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

Review 7.  Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.

Authors:  Weiwei Jiang; Xuhang Li
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

8.  MicroRNA-133α regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis.

Authors:  Ivy Ka Man Law; Charalabos Pothoulakis
Journal:  RNA Dis       Date:  2015

Review 9.  MicroRNAs in mucosal inflammation.

Authors:  Viola Neudecker; Xiaoyi Yuan; Jessica L Bowser; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2017-07-20       Impact factor: 4.599

Review 10.  How microRNAs influence both hereditary and inflammatory-mediated colon cancers.

Authors:  Jennifer Hutchison; Zoe Cohen; Benjamin C Onyeagucha; Janet Funk; Mark A Nelson
Journal:  Cancer Genet       Date:  2013-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.